Chromatography Resin Market Sales Reliant on Rising Adoption of Affinity Chromatography Resin Technology: FMI

ESOMAR-certified consulting firm Future Market Insights’ report projects the global chromatography resin market to rise at an impressive pace between 2021 and 2031. Growing adoption of affinity chromatography resin technology is expected to increase the demand of chromatography resins across the globe. Alongside this, increase in demand for monoclonal antibody production will improve the sales over the coming years.

Demand for chromatography resins is rising extensively within the biopharmaceutical companies and research institutes. Burgeoning adoption of synthetic chromatography resin for the separation of biosimilars and development of monoclonal antibodies will spur the growth.

As per the FMI’s analysis, affinity chromatography resin sales are set to grow at over 11.3% CAGR, to surpass a valuation of approx. US$ 879.6 Mn by 2031-end. However, stringent regulatory policies, availability of cost-effective alternatives, and high cost of the chromatography technologies are some of the factors limiting the market growth.

Increasing funding by governments and initiatives undertaken to curb the mortality rate due to non-communicable diseases will spur the adoption of chromatography resins across the globe. Also, increasing expenditure on the research & development of drug delivery among the industry giants will also boost the market demand.

Chromatography Resin Market

According to the FMI’s analysis, the global chromatography resins market is anticipated to reach a valuation of nearly US$ 2215 Mn, registering a steady growth at 6.90% CAGR between 2021 and 2031.

Key Takeaways from FMI’s Chromatography Resin Market Study

  • In terms of product type, synthetic chromatography resins are anticipated to witness higher growth compared to the native chromatography resins
  • Affinity chromatography resin technology is expected to lead the segment, exhibiting the growth at 11.3% CAGR
  • Biopharmaceutical companies will remain the largest end-users of chromatography resins across the globe, surpassing valuation of approx. US$ 900 Mn by 2031-end
  • Rising government initiatives to curb the non-communicable diseases across India will spur the market demand
  • The U.S. is expected to remain the largest market of chromatography resins throughout the forecast period
  • Germany and the U.K, collectively, will lead the Europe’s chromatography resin market owing to the rising prevalence of non-communicable disease
  • China is anticipated to emerge as a potential market on the back of rising adoption of advanced chromatography technologies within the region

Request a Complete TOC of this Report with figures:
https://www.futuremarketinsights.com/toc/rep-gb-1349

“Increasing research & development activities aimed at the development of economic monoclonal antibody drugs within the biopharmaceutical companies are expected to provide lucrative opportunities for the market players,” says the FMI analyst. 

Competitive Landscape

Agilent Technologies, Bio-Rad Laboratories Inc., GE Healthcare, Waters Corporation, Expedeon Ltd., Thermo Fisher Scientific Inc., Pall Corporation, Merck KGaA, PerkinElmer Inc., Kaneka Corporation, Shimadzu Corporation, Knauer GmbH, Tosoch Bioscience, Avantor Performance Materials Inc., Mitsubishi Chemical Corporation, W.R. Grace & Co., JSR Micro Inc., and Life Technology Corporation among others are some key players operating in the chromatography resin market.

As per the FMI’s analysis, the market is dominated by top 5 players in the global chromatography resin market, accounting for over 70% of market share. Top 5 players include Bio-Rad Laboratories, Inc., GE Healthcare, Tosoh Corporation, Merck KGaA, and Thermo Fisher Scientific Inc.

Market players operating in chromatography resins market are also forming tie-ups and targeted mergers & collaboration with other top healthcare companies for the expansion of their product portfolios.

For instance, in February 2021, Repligen Corporation, a global life sciences company focused on bioprocessing technology leadership, and Navigo Proteins GmbH, a prominent protein engineering company specializing in novel affinity ligand development, announced the commercial launch of NGL COVID-19 Spike Protein Affinity Resin, a novel affinity resin used in the purification of COVID-19 vaccines.

On February 4th, 2021 Avitide, another leading player, finalized the development of an affinity bioprocess resin, AVIPure-COV2S, for the purification of recombinant COVID-19 vaccines.

Scope of Report

AttributeDetails
Forecast Period2021-2031
Historical Data Available for2016-2020
Market AnalysisUSD Million for Value
Key Regions CoveredNorth America, Latin America, Europe, East Asia, South Asia, Oceania, and the Middle East & Africa
Key Countries CoveredUS, Canada, Germany, U.K., France, Italy, Spain, Russia, China, Japan, South Korea, India, Thailand, Malaysia, Indonesia, Australia, New Zealand, GCC Countries, Turkey, Northern Africa, and South Africa
Key Segments CoveredProduct Type, Technology Type, End User, and Region
Key Companies ProfiledAgilent TechnologiesBio-Rad LaboratoriesGE HealthcareWaters CorporationExpedeon LtdThermo Fisher Scientific Inc.Pall CorporationMerck KGaAPerkin Elmer Inc.Kaneka CorporationShimadzu CorporationKnauer GmbHTosoh BioscienceAvantor Performance Materials Inc.Mitsubishi Chemical CorporationW.R. Grace & Co.JSR Micro Inc.Life Technology CorporationOthers
Report CoverageMarket Forecast, Company Share Analysis, Competition Intelligence, DROT Analysis, Market Dynamics and Challenges, and Strategic Growth Initiatives
Customization & PricingAvailable upon Request

More Insights on the Global Chromatography Resin Market

In its latest report, FMI provides an incisive coverage on the global chromatography resin market, providing historical data for the period of 2016-2020 and forecast statistics for the period of 2021-2031. In order to understand the global market potential, its growth, and scope, the market is segmented on the basis of product type (native and synthetic), technology type (affinity chromatography, anion exchange chromatography, cation exchange chromatography, size exclusion, and hydrophobic interaction), end user type (biopharmaceutical companies, clinical research organizations, and academic institutes), and across major regions (North America, Latin America, Eastern Europe, Asia Pacific excluding Japan, Western Europe, Japan and Middle East & Africa)

About the Healthcare Division at Future Market Insights

Future Market Insights facilitates corporates, government, investors, and associated audiences in the healthcare sector to identify and accentuate vital aspects applicable to product strategy, regulatory landscape, technology evolution, and other crucial issues to achieve sustainable success. Our unique approach to gathering market intelligence equips you in devising innovation-driven trajectories for your business. Know more about our sector coverage here

Leave a comment

Your email address will not be published.